12:00 AM
 | 
Feb 15, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

AdVac tuberculosis vaccine: Preliminary Phase II data

Preliminary data from a double-blind, placebo-controlled, dose-escalation, South African Phase II trial in 72 patients who have completed TB treatment showed that AERAS-402/Crucell Ad35...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >